Sarah Kathryn Rouan's Net Worth

$0

Estimate Recalculated May 3, 2024 07:52PM EST

Who is Sarah Kathryn Rouan?

Sarah Kathryn Rouan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Viking Therapeutics, Inc., and NAVIDEA BIOPHARMACEUTICALS, INC..

SEC CIK

Sarah Kathryn Rouan's CIK is 0001761366

Past Insider Trading and Trends

2019 was Sarah Kathryn Rouan's most active year for acquiring shares with 1 total transactions. Sarah Kathryn Rouan's most active month to acquire stocks was the month of December. 2019 saw Sarah Kathryn Rouan paying a total of $0.00 for 55,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Viking Therapeutics, Inc. (VKTX) Snapshot price: $24.41

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$18.19
-$493,250.00
0
Scheduled
Feb 8
Form 4
—
0
$15.69
-$441,900.00
0
Scheduled
Jan 19
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
No matching records found

NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Snapshot price: $0.0385

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found